109 related articles for article (PubMed ID: 3663135)
1. Characterization of N-linked oligosaccharides of an HLA-DR molecule expressed in different cell lines.
Néel D; Merlu B; Turpin E; Rabourdin-Combe C; Mach B; Goussault Y; Charron DJ
Biochem J; 1987 Jun; 244(2):433-42. PubMed ID: 3663135
[TBL] [Abstract][Full Text] [Related]
2. Analysis of HLA-DR antigen glycosylation by serial lectin affinity chromatography.
Neel D; Giner M; Merlu B; Turmel P; Goussault Y; Charron DJ
Mol Immunol; 1985 Sep; 22(9):1053-9. PubMed ID: 3865052
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation of human leukocyte locus A molecules is dependent on the cell type.
Merlu B; Neel D; Goussault Y; Charron DJ
Eur J Biochem; 1989 May; 181(3):755-60. PubMed ID: 2543568
[TBL] [Abstract][Full Text] [Related]
4. Analysis of normal human tonsil class II antigen glycosylation by lectin affinity chromatography.
Zacheis M; Giacoletto K; Schwartz BD
J Biol Chem; 1986 Dec; 261(36):17004-10. PubMed ID: 3782152
[TBL] [Abstract][Full Text] [Related]
5. HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure.
Alexander S; Hubbard SC; Strominger JL
J Immunol; 1984 Jul; 133(1):315-20. PubMed ID: 6609984
[TBL] [Abstract][Full Text] [Related]
6. Invariant chain influences post-translational processing of HLA-DR molecules.
Schaiff WT; Hruska KA; Bono C; Shuman S; Schwartz BD
J Immunol; 1991 Jul; 147(2):603-8. PubMed ID: 2071896
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the oligosaccharides on the HLA-DR and DC1 B cell antigens.
Shackelford DA; Strominger JL
J Immunol; 1983 Jan; 130(1):274-82. PubMed ID: 6600184
[TBL] [Abstract][Full Text] [Related]
8. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
9. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen.
Gay D; Maddon P; Sekaly R; Talle MA; Godfrey M; Long E; Goldstein G; Chess L; Axel R; Kappler J
Nature; 1987 Aug 13-19; 328(6131):626-9. PubMed ID: 3112582
[TBL] [Abstract][Full Text] [Related]
10. Microheterogeneity and oligosaccharide chains on the beta chains of HLA-DR, human major histocompatibility complex class II antigen, analyzed by the lectin-nitrocellulose sheet method.
Kijimoto-Ochiai S; Hatae T; Katagiri YU; Okuyama H
J Biochem; 1989 Nov; 106(5):771-7. PubMed ID: 2515191
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the N-linked glycopeptides of DQw1 and DR1 molecules.
Iturbe S; Narasimhan S; Merrick JM; Falk JA; Letarte M
J Immunol; 1986 Jun; 136(12):4588-95. PubMed ID: 3486905
[TBL] [Abstract][Full Text] [Related]
12. Monensin prevents terminal glycosylation of the N- and O-linked oligosaccharides of the HLA-DR-associated invariant chain and inhibits its dissociation from the alpha-beta chain complex.
Machamer CE; Cresswell P
Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1287-91. PubMed ID: 6608726
[TBL] [Abstract][Full Text] [Related]
13. [HLA-DR antigens: cellular expression and molecular structure].
Charron DJ
Ann Immunol (Paris); 1982; 133D(2):155-69. PubMed ID: 6187269
[TBL] [Abstract][Full Text] [Related]
14. A novel HLA class II molecule (DR alpha-DQ beta) created by mismatched isotype pairing.
Lotteau V; Teyton L; Burroughs D; Charron D
Nature; 1987 Sep 24-30; 329(6137):339-41. PubMed ID: 3306409
[TBL] [Abstract][Full Text] [Related]
15. Type analysis of oligosaccharide chains on human and murine MHC class II alpha chains by the lectin-nitrocellulose sheet method.
Katagiri YU; Kijimoto-Ochiai S; Hatae T; Okuyama H
Comp Biochem Physiol B; 1989; 93(2):259-63. PubMed ID: 2550173
[TBL] [Abstract][Full Text] [Related]
16. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
[TBL] [Abstract][Full Text] [Related]
17. Isolation of cDNA clones for the p33 invariant chain associated with HLA-DR antigens.
Long EO; Strubin M; Wake CT; Gross N; Carrel S; Goodfellow P; Accolla RS; Mach B
Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5714-8. PubMed ID: 6412232
[TBL] [Abstract][Full Text] [Related]
18. Structural analysis of the oligosaccharides of DR1 and DQw1 molecules.
Iturbe S; Narasimhan S; Letarte M
J Immunol; 1986 Jun; 136(12):4596-603. PubMed ID: 3486906
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus (EBV) latent membrane protein 1 increases HLA class II expression in an EBV-negative B cell line.
Zhang Q; Brooks L; Busson P; Wang F; Charron D; Kieff E; Rickinson AB; Tursz T
Eur J Immunol; 1994 Jun; 24(6):1467-70. PubMed ID: 8206105
[TBL] [Abstract][Full Text] [Related]
20. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
